Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) declared that it has started a public offering of common stock by selling stockholders. The selling shareholders have decided to present 15,000,000 shares of Class A common stock of Maravai. The offer is in accordance with a registration declaration on Form S-1 submitted with the SEC.

Furthermore, the selling shareholders have also disclosed that they have provided an offer to the underwriter. As per the new offer, the underwriter will get an option to buy up to an extra 2,250,000 shares of Class A common stock of MRVI.

Shares of Maravai LifeSciences soared 1.20% at $34.58 during the trading session of Monday. In the past 52-weeks, the share of the firm fluctuated between $23.62 from its 52-week low range and $40.24 from its 52-week high range. The share of the firm soared 46.40% from its 52-week low and went down -14.07% from its 520week high. MRVI's market capitalization has remained high, reaching $9.29 billion at the time of writing.

It has been disclosed that Maravai LifeSciences will not get any profit from the sale of shares by the selling stockholders. The joint book-running manager and spokespersons of the underwriters for the proposed offering are Jefferies, Morgan Stanley, and Goldman Sachs & Co. LLC.